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Human Organotypic Cultured 
Cardiac Slices: New Platform For 
High Throughput Preclinical Human 
Trials
C. Kang1,2, Y. Qiao1,2, G. Li1, K. Baechle1, P. Camelliti3, S. Rentschler1 & I. R. Efimov1,2,4,5
Translation of novel therapies from bench to bedside is hampered by profound disparities between 
animal and human genetics and physiology. The ability to test for efficacy and cardiotoxicity in a 
clinically relevant human model system would enable more rapid therapy development. We have 
developed a preclinical platform for validation of new therapies in human heart tissue using organotypic 
slices isolated from donor and end-stage failing hearts. A major advantage of the slices when compared 
with human iPS-derived cardiomyocytes is that native tissue architecture and extracellular matrix 
are preserved, thereby allowing investigation of multi-cellular physiology in normal or diseased 
myocardium. To validate this model, we used optical mapping of transmembrane potential and calcium 
transients. We found that normal human electrophysiology is preserved in slice preparations when 
compared with intact hearts, including slices obtained from the region of the sinus node. Physiology is 
maintained in slices during culture, enabling testing the acute and chronic effects of pharmacological, 
gene, cell, optogenetic, device, and other therapies. This methodology offers a powerful high-
throughput platform for assessing the physiological response of the human heart to disease and novel 
putative therapies.
Motivation
Cardiovascular research on the mechanisms of heart failure and sudden death has been conducted primarily in 
animal models with varying degree of clinical relevance. While animal models are indispensable in advancing 
basic cardiac biology, their translational potential is being challenged due to a paucity of successful translation 
from bench to bedside in recent years1,2. Recently, we explored a growing opportunity to augment applied car-
diovascular research using live donor and failing human hearts, which provide important insights into human 
physiology and pharmacology.
Significance. Despite significant effort and investment from the cardiovascular research community, current 
heart failure therapies are primarily based on very old ideas, including β -blockers, diuretics, heart transplanta-
tion, pacemakers, defibrillators, and ventricular assist devices. New approaches, including gene and cell therapies 
and tissue engineering, are yet to prove clinical relevance, while survival rates on a typical drug regimen remain 
approximately 1 year3. The typical heart failure drug regimen includes angiotensin blockers, β -blockers, calcium 
channel blockers, anticoagulants, antiplatelets, vasodilators, and digitalis, which do little to address the under-
lying etiology of heart failure4. As heart failure burden increases with age, it is very difficult for older patients to 
keep up with the cost and complexity of these drug regimens5. Novel drug development is a slow and expensive 
process due in a large degree to the lack of reliable high throughput screening technology preceding clinical trials. 
Limited genetic and physiological relevance of many animal models of heart failure to the human condition also 
results in very low clinical translation of new therapies6.
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Comparison of current models. There are substantial barriers impeding the translation of discoveries 
made in animal models into humans, including scarcity of clinically relevant in vitro human model systems for 
evaluation of putative therapies. The organotypic tissue slice is a widely used technique to study diverse organ 
systems, including the brain, kidney, and liver7,8. We have adopted this technique to human cardiac tissue, pro-
viding us with a multicellular model system enabling mechanistic studies of cardiac physiology and gene therapy 
approaches in a human primary substrate system. There are several unique advantages that the cardiac organo-
typic slice culture model affords over well established models. First, the lack of multi-cellularity and intercellular 
contacts make isolated cells unsuitable for investigation of multi-cellular events such as cell-cell communica-
tion, cardiac conduction, and arrhythmia. Additionally, the chunk dissociation procedure used to study isolated 
human cell electrophysiology utilizes an enzymatic digestion step that appears to significantly degrade selected 
potassium channel function9. While iPS cells are very useful for lineage specification and developmental electro-
physiology studies10,11, it remains challenging to differentiate iPS cells into mature, rod-like quiescent adult atrial 
or ventricular myocytes. Finally, coronary perfused intact tissue preparations (wedge preparations) provide a well 
established system to study intact tissue-level physiology, however, preparations are large and require coronary 
perfusion limiting the number of preparations that can be dissected from a human heart12,13. Furthermore, wedge 
preparations can only be maintained for several hours, which prevents long-term chronic experimental investi-
gation, including gene expression and proliferative responses. Despite these advantages over currently utilized 
models, cardiac slices are not designed to replace, but rather, to fill a niche among them. Isolated myocytes remain 
the only model to study specific ionic currents, iPSC-derived cardiomyocytes can provide patient specific therapy 
screening, and coronary perfused preparations provide detailed insight into three dimensional conduction and 
arrhythmia properties within tissues (Supplemental Table 1).
Current state of cardiovascular slice. Several recent publications have indicated that the cardiac slice 
preparation has an enormous untapped potential to augment and bridge the currently utilized isolated primary 
cells and coronary perfused heart preparations6,14,15. Organotypic slices preserve the native tissue environment, 
allowing normal contacts with extracellular matrix and intercellular communication, which facilitates the 
maintenance of the differentiated adult cardiomyocyte phenotype16–18. Several publications demonstrated that 
slices from rabbit, guinea pigs, mouse, and canine hearts exhibit similar electrophysiology to the intact heart via 
multi-electrode array measurements15,17. Additionally, acute delivery of drugs including the hERG-type potas-
sium channel blocker, E-4031, and the slow delayed rectifier potassium channel blocker, chromanol 293B, have 
exhibited a comparable effect in slice versus coronary perfused preparations17. Furthermore, slices have previ-
ously shown robust survivability in culture. However, significant mechanical and electrophysiological remodeling 
was noted during long-term culture in these studies16.
Most prior electrophysiology studies relied on multi-electrode arrays, which are limited by the low electrode 
density (8 × 8 to 16 × 16 electrodes) and the inability to capture action potential morphology17–19. In contrast, 
optical mapping has a far higher resolution of 100 × 100 or more pixels and the ability to map action potentials, 
calcium transients, mitochondrial inner member potential, etc.20 In this study, we aimed to develop adult human 
cardiac slices from atria and ventricles as a preclinical screening platform for novel drug, gene, or other types of 
therapies. Utilizing the optical mapping technique, we provide a high-resolution electrophysiological characteri-
zation of adult human atrial and ventricular slices subjected to drugs and viral gene delivery vectors, in fresh slices 
and following 24–96 hours in culture.
Methods
Human tissue acquisition. Adult human hearts were procured either as failing human hearts from Barnes-
Jewish Hospital (St. Louis, MO) or Inova Fairfax Hospital (Fairfax, VA), and as donor human hearts from Mid-
America Transplant Services (St. Louis, MO) or Washington Regional Transplant Community (Washington, DC). 
Experimental protocols were approved by both Washington University and the George Washington University 
Institutional Review Boards (IRBs). Informed donor consents were obtained for all tissue used in this study. Methods 
described in this section were performed in accordance with all human research guidelines. Explanted hearts 
were cardioplegically arrested via high potassium solution (in mmol/L: NaCl 110, CaCl2 1.2, KCl 16, MgCl2 16, 
NaHCO3 10) and were cooled to + 4 °C in the operating room following aortic cross-clamp. Failing hearts were 
perfused through both coronaries, while donor hearts were perfused systemically prior to removal from the chest. 
The heart was maintained at this low temperature to preserve tissue during the 15–20 minute transportation time 
from the operating room to the research laboratory.
Slice preparation. Upon arrival, an approximately 1cm by 1cm cube of left ventricular tissue or right atrial 
tissue was cut in cardioplegic solution. Left ventricular tissue was taken from a region close to the left anterior 
descending artery and circumflex artery. Atrial tissue was taken from the crista terminalis below the sinoatrial 
node region. Premade 4% agarose gel cooled at 4 °C was glued on to the tissue holder of a high precision vibrating 
microtome (7000 smz-2, Campden Instruments Ltd. UK). The tissue block was then mounted with the endo-
cardium up on the agarose. Agarose did not prevent tissue superfusion. Slices were cut tangential to the endo-
cardium. The cutting chamber was filled with cold (4 °C) oxygenated (100% O2) modified Tyrode’s solution with 
excitation contraction uncoupler 2,3-butanedione (Tyrode’s cutting solution, in mM: NaCl 140; KCl 6; glucose 10; 
HEPES 10; MgCl2 1; CaCl2 1.8; BDM 10; pH 7.4)17. The outer chamber is constantly refilled with ice to maintain 
constant 4 °C in the cutting chamber.
The microtome was pre-set to 380 μ m cutting thickness, 0.02–0.03 mm/s advance speed, 2 mm horizontal vibra-
tion amplitude, and 80 Hz vibration frequency. The microtome’s z-axis vibration was also calibrated prior to each 
experiment with the ceramic cutting blade to < 0.5 μ m, which limited damage to a single layer of cardiomyocytes 
during the cutting procedure. After each slice was cut, they were transferred immediately to oxygenated (100% O2) 
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washout solution at 20 °C (Tyrode’s recovery solution, in mM: NaCl 140; KCl 4.5; glucose 10; HEPES 10; MgCl2 1; 
CaCl2 1.8; 1% Penicillin-Streptomycin; pH 7.4). Slices were placed in 100 μ m nylon mesh cell strainers in 6 well 
plates with a bottom drilled through for oxygenation. A meshed washer was placed on top of the slice to prevent 
the tissue from curling. The tissue slices were kept in the washing solution for 20 minutes to washout the BDM 
and warm the tissue gradually to room temperature. The tissue could stay in washout solution at room tempera-
ture for up to 12 hours for acute electrophysiology studies.
Acute optical mapping for electrophysiology and drug response. Ventricular slices were elec-
trophysiologically studied with the optical mapping technique as published previously20. All optical mapping 
studies for both fresh and cultured slices were performed in the washout solution (Tyrode’s recovery solution) 
described above at 37 °C. To eliminate transmural and spatial heterogeneity in the ventricle, we used slices from 
the sub-endocardium on the anterior of the left ventricle for both validation and chronic drug studies. Optical 
data was acquired using an Ultima-L CMOS camera system (SciMedia). Transmembrane potential (Vm) was 
measured using di-4-ANEPPS and RH237 (Life Technologies). Intracellular calcium [Ca2+] was measured using 
Rhod-2AM (Life Technologies). The dye were loaded very slowly on top of the tissue and allowed to incubate 
for up to 30 minutes. The excitation-contraction uncoupler, blebbistatin (Cayman Chemical), was also loaded in 
a similar manner. Using a 50 mm Nikon lens, a 1 × 1 cm field of view was projected to a 100 × 100 pixel CMOS 
sensor. This ensured that nearly the entire field of view was taken up by tissue to maximize resolution. Optical 
action potential was captured every 10 minutes during the dye incubation period to ensure optimal signal quality.
Acute electrophysiology measurement included optical mapping of Vm and [Ca2+] during a restitution pacing 
protocol. These parameters included action potential duration (APD), activation sequence, calcium transient 
(CaT) duration and morphology, conduction velocity (CV), restitution properties, and effective refractory period 
(ERP). Basic drug response was examined using saturated dosage of isoproterenol (100 nM). All ventricular slices 
did not exhibit automaticity and were paced with custom designed platinum rod field/array pacing chamber. The 
pacing stimulus was set at twice the amplitude of the pacing threshold and 2 ms pulse duration. Some atrial slices 
obtained near the crista terminalis exhibited automaticity, but they were paced to acquire standardized action 
potential or calcium transient characteristics.
Culture procedure, materials, and validation. Slices were cultured in medium 199 (M4530, Sigma 
Aldrich) supplemented with 2% penicillin-streptomycin, 1 X ITS (Insulin, Transferrin, Selenium) liquid media 
supplement, and 10 mM 2,3-butanedione monoxime. Slices were individually washed in sterile PBS solution 6 
times before placing in culture. Sterile forceps were used to handle slices at all time. Slices were cultured at a 
liquid-air interface using porous transwell inserts (PICM0RG0, Millipore, USA). Inserts were placed in 6-well 
culture plates with 1.1 ml culturing medium and placed in a 37 °C incubator with humidified air with 5% CO2. 
The culture medium was changed daily. After a 24 hour culture period, slices’ electrophysiology was measured 
with optical mapping to examine potential functional changes occurred during culture. APD, action potential 
morphology, and restitution properties were examined following the same protocol as under acute conditions. 
A newer iteration of this process simplifies this procedure by removing the PBS wash step in favor of autoclaving.
Chronic drug model. Utilizing cultured slices and an adult dosage of phenylephrine, a widely used selective 
α 1-adrenergic receptor agonist, we developed a model to study chronic drug effects in human cardiac slices. Slice 
electrophysiology was first acutely measured using optical mapping after application of 3 μ M phenylephrine, 
which was chosen for this study because it is an average of the EC50 values found in the literature21–23. Then 
acute slices were placed in either control culture with standard culture medium described above or drug medium 
including 3 μ M phenylephrine. Slices were cultured in a tissue incubator for 24 hours. Control cultured slices were 
measured before and after phenylephrine application similar to acute slices, slices cultured in drug media were 
measured separately. We also utilized custom made platinum tipped electrodes for point simulation of slices. This 
allowed us to more accurately characterize conduction velocity. Only transverse conduction velocity could be 
measured accurately due to the small size of the tissue.
Adenoviral transduction and expression of green fluorescent protein. To increase depth of viral 
tissue penetration and achieve greater viral transduction efficiency, slices were treated with collagenase after they 
were placed on transwell inserts. 15 μ L of Type 2 collagenase (Worthington Biochem) reconstituted at 250 units/mL 
in slice culture medium was pipetted onto each slice and placed in a tissue incubator for 20 minutes. The slices 
were subsequently washed in the wells after the incubation period, followed by addition of 1.1 mL of the culture 
medium to the Transwell. Ad5-GFP (total of 1.11e10 viral particles, 2.82e12 v.p./mL) encoding eGFP and lucif-
erase driven by the cytomegalovirus promoter was diluted in a total volume of 12 uL PBS, pipetted onto each slice 
to cover completely, and incubated on the slice for 2–12 hours.
Histology and Immunohistochemistry. Post experiment, slices are preserved in O.C.T. compound 
(Tissue-Tek), frozen and sectioned transmurally. Immunohistochemistry was performed using antibod-
ies directed against Connexin 43 (Life Technologies 710700, 1:100 dilution) and α -actinin (Sigma A2172 
MFCD00164521, 1:100 dilution). Masson’s trichrome staining was performed as described previously24.
Data analysis methods. A custom data analysis program, Rhythm, developed in our laboratory for optical 
mapping data was used to analyze Vm and [Ca2+]25. Action potential and calcium transient optical signals were 
low-pass filtered at 100–150 Hz, spatially averaged at 3 × 3 pixels, normalized from 0 to 1, and fluorescent drift 
was removed with a first-order fitted curve, if needed. All sample averages are presented with standard error of 
the mean (S.E.M), which appears as error in figures with bar graphs comparing means. Standard deviation (S.D.) 
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is used in restitution curves. Comparative statistic is performed using one-way ANOVA with post-hoc Tukey 
honestly significant difference (HSD) test for multiple comparisons unless otherwise noted.
The activation map was plotted via calculating activation time points at 50% of action potential upstroke 
amplitude. Action potential and calcium transient duration was calculated at 80% repolarization/relaxation. 
When slices were field-paced, conduction velocity could not be quantified via traditional longitudinal and trans-
verse direction. During point pacing we calculated conduction velocity using a semi-automated Matlab function 
ORCA26. Effective refractory period was measured using S1-S1 pacing protocol until 1:1 capture was lost. Action 
potential and calcium transient were recorded at pacing cycle lengths from 2000 ms to 200 ms.
Results
Cardiac slice preparations have been previously utilized in small human biopsies and animal hearts16,17, however, 
systematic slicing protocols have yet to be adapted for the explanted human heart. In collaboration with heart 
transplantation programs and organ procurement organizations in St. Louis, MO and Washington, DC, we estab-
lished a robust pipeline for applied human heart research27. Hearts were procured from either end stage heart 
failure patients at the time of transplantation, or from non-failing donors that were not acceptable for transplan-
tation. Figure 1 illustrates the methodology of slicing human atrial and ventricular tissue. In this example, atrial 
slices were taken from the crista terminalis region bordering the sinoatrial (SA) node, while ventricular slices 
were taken from the left or right ventricular free wall. The block of tissue is placed on a tissue holder with a back 
support, which prevents the tissue from sliding during slicing. Slices were cut tangentially to the epicardium while 
paying careful attention to the layer (i.e. subendocardial, subepicardial), because cellular electrophysiology is 
known to change gradually from the epicardium to the endocardium28. After slices were placed in Tyrode’s recov-
ery solution, acute recordings were performed in different tissue layers to determine baseline electrophysiology.
Quantification of electrophysiology utilizing optical mapping. Multi-electrode arrays are a pop-
ular and easy to use tool for assessment of cardiac and neural electrophysiology. In contrast to multi-electrode 
array, optical mapping of cardiac slices has been shown to faithfully reproduce morphology of action potentials 
in animal cardiac slices20. Here, we apply multiparametric optical mapping for the first time in human atrial and 
ventricular slices both acutely and after culture.
Figure 2 summarizes a broad electrophysiological assessment of ventricular slices illustrating the robustness 
of this model for applied human research. Slices from the left ventricular free wall from either donor or failing 
hearts were sectioned. Electrophysiology was mapped with high spatial and temporal resolution either acutely, or 
after 24 hours of culture, with or without pharmacological treatment (Fig. 2a,b). Activation was measured at 50% 
of depolarization, and conduction velocity (CV) was measured from the activation sequence. AP duration (APD) 
was calculated by measuring the time between activation and repolarization completed by 80%. Figure 2c pre-
sents a typical activation map during field stimulation. To determine whether slices preserve drug responsiveness, 
we employed well-characterized drugs. A typical response to β -adrenergic stimulation is increased CV and short-
ened APD29,30. Donor left ventricular slices paced at 1 Hz (60 beats per minute) exhibited a CV of 0.67 ± 0.008 m/s 
(± S.E.M) at baseline (n = 13), with an increased CV of 0.84 ± 0.02 m/s during β -adrenergic stimulation with 
isoproterenol (n = 4) (Fig. 2d, p = 0.016, one-way ANOVA with post-hoc Tukey HSD). As expected, heart failure 
caused slowing of CV at baseline to 0.47 ± 0.003 m/s (n = 7), but isoproterenol increased CV to 0.54 ± 0.003 m/s 
(Fig. 2d, n = 3, p = 0.022, two tailed t-test assuming unequal variances). Importantly, 24 hour culture did not affect 
CV in donor slices (0.66 ± 0.002 m/s, n = 5) versus baseline (Fig. 2d). Culture degraded the electrical properties of 
failing slices, therefore we did not include them in subsequent culture studies. This degradation could result from 
the fact that the end stage failing hearts exhibit a significantly greater degree of fibrosis, depraved metabolic state, 
Figure 1. Organotypic Human Cardiac Slice Methodology. Human atrial and ventricular slices were 
procured from both (a) non-failing donor (D) and end stage failing (F) hearts. (b) 1cm × 1cm samples from 
either the left ventricle or the atria were prepared for sectioning. (c) Up to 30 sections were made using a 
vibratome at a cutting rate of 0.02–0.04 mm/s in ice-cold oxygenated modified Tyrode’s solution. (d) Slices were 
conditioned at room temperature for 20 minutes before use for either (e) electrophysiology optical mapping, 
and/or culture and viral transduction.
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and structural degradation at baseline, which are compounded during culture, leading to drastically decreased 
survival.
Figure 2e shows a typical map of slice ventricular APD, demonstrating a similar baseline APD in slices 
(337 ± 7 ms, n = 10) when compared with the “gold standard” coronary perfused left ventricular wedge prepara-
tions (322 ± 5 ms, n = 7) (Fig. 2f). As expected, β -adrenergic stimulation of slices resulted in a significant decrease 
of APD from baseline to 284 ± 9 ms (n = 5) (p = 0.017, one-way ANOVA with post-hoc Tukey HSD), similar to the 
decrease from baseline to 290 ± 6 ms (n = 7) seen in wedge preparations (p = 0.021, Fig. 2f). Importantly, APD 
was also maintained after 24 hours in culture (337 ± 7 ms, n = 10) when compared with acute slices (339 ± 13 ms, 
n = 5, p = 0.99), which validates this model for use in chronic studies of repolarization (QT toxicity) (Fig. 2f).
Multi-parametric optical mapping. We also conducted multi-parametric optical mapping in car-
diac slices by combining transmembrane potential (Vm) sensitive dye and cytosolic calcium (Ca) sensitive dye 
(Fig. 3a). Using optical AP and calcium transient (CaT) recordings, we measured restitution properties (wave-
form duration versus stimulation cycle length) (Fig. 3b,c). As expected, a significant difference was observed in 
donor versus failing CaT duration (321 ± 18 ms vs 418 ± 20 ms at 1000 ms cycle length; n = 3, p = 0.0062, two 
tailed t-test assuming unequal variances). APD and CaT duration were significantly different between donor and 
Figure 2. Electrophysiological Properties of Human Ventricular Slices. (a) Bright field image of a ventricular 
slice with sample optical signals from various regions illustrating high signal to noise ratio.  
(b) Action potentials (AP) at 1 Hz pacing frequency (1000 ms pacing cycle length) of failing versus donor slices 
at baseline and β -adrenergic receptor (AR) stimulation conditions. (c) Activation map from a slice during 
electrical field stimulation demonstrating anisotropic conduction. (d) Quantitative summary of conduction 
velocity showing increased velocity during β -AR stimulation in both donor and failing slices, while culture 
process does not significantly alter conduction. (e) Map of AP duration (APD80) at 1 Hz pacing. (f) Comparison 
of APD80 at 1 Hz pacing frequency in fresh slices, slices cultured for 24 hr, and in the well-established human 
coronary perfused ventricle preparation (wedge) model. No significant difference is observed among models. 
Furthermore, β -AR stimulation decreases APD80 to a similar degree in slices and wedge preparations, 
demonstrating viability of the ventricular slice model for use in drug testing.
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Figure 3. Comparison of Action Potentials and Calcium Handling in Human Ventricular Slices. 
Action potentials (AP) and calcium transients (CaT) were recorded from the same slices stained with 
voltage- and calcium-sensitive dyes. (a) Comparison of local AP and CaT optical signal obtained from 
the respective donor and failing slices. (b) The baseline APD restitution curve is higher in failing versus 
donor slices, as expected. (c) CaT restitution curves demonstrate a similar difference in failing slice 
when compared with donor slices to that observed in AP. (d) Baseline restitution curve of donor slices 
is similar to that measured previously in coronary perfused wedge preparations. Acute β -adrenergic 
stimulation significantly lowers the restitution curve, while culturing slices for 24 hrs did not alter the 
restitution curve. (e) Slices obtained from failing hearts also demonstrate a response to acute β -adrenergic 
stimulation.
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failing hearts at most pacing cycle lengths (Fig. 3b,c, one-way ANOVA with post-hoc Tukey HSD for each cycle 
length) similar to previous reports utilizing wedge preparations13,30, providing further validation of our tissue slice 
model. As expected, β -adrenergic stimulation shifted the restitution curve downwards in both donor and failing 
slices. Culture did not change restitution properties (Fig. 3d,e).
Characterization of atrial muscle and SA nodal electrophysiology. One of the critical advantages 
of the cardiac slice model is the ability to study any region of the heart regardless of availability of a branch of cor-
onary artery required for perfusion in wedge preparations and/or size of the tissue sample. Previously, coronary 
perfusion was required to study human atrial and SA or AV nodal tissues31,32. Tissue slices can be sustained by 
superfusion as their thickness is below diffusion limit of oxygen, ~300–400 μ m. Figure 4 illustrates our ability to 
optically map either AP or CaT in superfused atrial and SA nodal slices. A slice from the CT region bordering SA 
node is illustrated in Fig. 4a. In contrast to the ventricular optical AP and CaT, which are relatively homogeneous 
within each slice, optical CaT from the CT region consisting of both SA nodal and working atrial tissue exhibits 
significant heterogeneity in AP and CaT morphology and duration (Fig. 4b,c). Two distinctly different upstroke 
durations and morphologies of CaT were observed: SA nodal cells exhibited slow upstrokes and long duration of 
CaT (black, cyan, and purple), while the working atrial myocardium exhibited faster upstrokes and shorter CaT 
duration (blue, green, and orange). Furthermore, restitution pacing revealed heterogeneous effective refractory 
periods. At long pacing cycle length, we observed 1:1 capture in all regions. As pacing cycle length decreased, 
SA nodal tissue first lost 1:1 capture and then exhibited automaticity at ~1 Hz, which corresponds to a normal 
heart rate (Fig. 4d, black tracing). Simultaneously, the atrial muscle regions maintained 1:1 response as expected 
(Fig. 4d, blue trace). We also determined the inherent automaticity of slices from the SA node. Figure 4e illustrates 
optical AP recordings recorded during pacing at long cycle length of 2000 ms (30 beats per minute), where we 
observe both capture of paced beats as well beats originating from competing SA node firing once a second. With 
no stimulation, spontaneous SA nodal automaticity was observed (Fig. 4e). In contrast, ventricular and atrial 
muscle slices lacking the SA nodal region are electrically quiescent (Supplemental Fig. 1). We also quantified 
restitution properties in donor atrial muscle tissue for both AP and CaT (Fig. 4f). At 1 Hz stimulation, APD was 
234 ± 16 ms (n = 3) and CaT duration was 219 ± 11 ms (n = 3). These atrial durations were significantly shorter 
than donor left ventricular APD and CaT duration (p = 0.0032, p = 0.002, two tailed t-test assuming unequal 
variances ), in accordance with previous published APD data from coronary perfused preparations12,33. To our 
knowledge, this represents the first report of CaT data from both SA node and atria of the human heart.
Novel adult human model to study chronic remodeling via drug stimulation. As demonstrated 
in Fig. 2, cardiac slices have a normal physiologic response to β -adrenergic stimulation. Yang et al. have recently 
shown the importance of also considering long-term drug responses when assessing cardiac drug efficacy and 
toxicity34. Using fresh and cultured ventricular slices, we developed a model of human cardiac remodeling under 
extended α 1-adrenergic stimulation using 3 μ M phenylephrine, an active compound of commonly used nasal 
spray.
Figure 5a illustrates the timeline of the study. Figure 5b shows representative APD changes from baseline 
under different conditions. Importantly, APs at baseline recorded in fresh slices were no different from APs after 
culture in the absence of phenylephrine (cyan versus blue AP traces). Short-term application of phenylephrine 
in both fresh and cultured slices (red and purple AP traces, respectively), results in similar APD increases, as 
expected. In contrast, chronic α 1-stimulation decreases APD (green AP trace). These changes in repolarization 
were further quantified through the restitution protocol (Fig. 5c,d), and individual values for APD and CV at 
1 second pacing cycling length are plotted (Fig. 5e,f). Short-term α 1-stimulation of fresh and cultured slices 
shifted the restitution curves significantly upwards, while chronic α 1-stimulation shifted the restitution curve 
downwards. Given that the upward shift in the restitution curve in response to short-term α 1-stimulation is sim-
ilar in both acute and cultured slices (Fig. 5c,d, one-way ANOVA with post-hoc Tukey HSD for each cycle length), 
this suggests that cultured slices maintain normal physiologic responses.
To illustrate these differential changes we present quantification of APD recorded during pacing at 1 Hz. 
Fresh slices exhibited an APD of 368 ± 9 ms (n = 8) at baseline, while short-term α 1-stimulation lengthened 
APD to 432 ± 9 ms (n = 6, Fig. 5e, p = 0.035, one-way ANOVA with post-hoc Tukey HSD). Slices cultured with-
out α 1-agonist exhibited APD of 357 ± 6 ms (n = 5), which increased to 401 ± 12 ms (n = 3) after short-term α 1 
-stimulation (p = 0.022), similar to the increase in fresh slices. Interestingly, 24-hour chronic α 1-stimulation, 
decreases the APD to 313 ± 20 ms (n = 3, p = 0.0047). These quantitative changes in APD lengthening in response 
to short-term α 1-stimulation are similar to that observed previously in animal models35–37. However, our stud-
ies also reveal that prolonged α 1-stimulation produces an opposite response in the APD, which has never been 
reported previously. Thus, we revealed potentially QT-toxic human effects of a commonly used nasal spray.
In order to accurately measure transverse conduction velocity, we used point stimulation of the slice instead 
of field stimulation in this experiment. Representative slice activation maps are shown in Supplemental Fig. 2. 
We find that CV also changes differentially with varying lengths of α 1-stimulation (Fig. 5f). At 1 Hz pacing, fresh 
baseline slices exhibited transverse conduction velocity (CVt) of 0.37 ± 0.01 m/s, but short-term α 1-stimulation 
slowed CVt to 0.25 ± 0.02 m/s (p = 0.035, one-way ANOVA with post-hoc Tukey HSD). Cultured control slices 
exhibit baseline CVt of 0.34 ± 0.03 m/s, which decreases to 0.26 ± 0.02 m/s after short-term α 1-stimulation 
(p = 0.044). In contrast, chronic α 1-stimulation significantly accelerates CVt to 0.42 ± 0.02 m/s when compared 
with fresh (p = 0.011) or chronic (p = 0.038) untreated slices.
Adenoviral-mediated gene expression in adult human ventricular slices. Due to significant 
genetic and physiological differences between animal and human heart, putative therapies developed in animal 
models could fail in humans, or may exhibit unanticipated adverse effects in clinical trials. The ability to express 
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Figure 4. Measurement of Action Potentials and Calcium Handling in Human Atrial Slices. Action 
potential (AP) and calcium transient (CaT) can be measured in the human atria utilizing the slice model.  
(a) Whole atrial preparation prior to sectioning. Boxed region of the crista terminalis bordering the sinus node 
is shown in panel b. (b) Representative CaT recorded from various regions of an atrial slice. (c) CaT recorded 
from distinct atrial regions demonstrates heterogeneity in the CaT morphology. Faster Ca release and uptake 
(blue, green, and orange traces) were observed in regions of contractile atrial myocardium, while slower CaT 
upstroke and recovery (black, cyan, and purple traces) were recorded in the sinus node area. (d) Pacing at 
normal heart rates (1 Hz) resulted in complete CaT capture of both atrial and SAN regions, while at higher 
pacing frequencies (2 Hz) regional conduction block was observed only in the sinus node region due to the 
longer effective refractory period. (e) Pacing atrial slices containing the sinus node cells at various frequencies 
(0.5 Hz upper panels, 1 Hz middle panels, and no pacing lower panels) demonstrates normal sinus node activity 
with both spontaneous and captured AP. (f) Restitution curves of AP duration and CaT in atrial myocardium 
demonstrating shorter AP and Ca durations when compared with ventricular slices.
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exogenous genes within adult human myocardium could improve the understanding of human physiology and 
enable rapid screening and translation of putative therapies from the T0 to clinical trial stage. Specifically, the 
potential for cardiac slices to serve as an in vitro model of the adult human heart, both healthy and failing, may 
accelerate the development of gene therapy approaches. Here we demonstrate initial proof of concept that cardiac 
slices can be virally transduced and express an exogenous protein using adenovirus. In these studies, we extend 
the slice culture time to 96 hours to allow sufficient time for expression of virally-encoded eGFP and determine 
whether expression is maintained throughout culture. Adenoviral transduction shortly after harvesting slices 
resulted in expression of virally-encoded eGFP before 24 hrs (not shown), with maintenance of eGFP expression 
at 48–96 hrs (Fig. 6a). Slices were co-stained with an antibody recognizing the sarcomeric protein α -actinin, 
demonstrating localization of eGFP within myocytes, as well as eGFP expression within non-myocytes. The sar-
comeric structure (Fig. 6a) and general tissue architecture (Fig. 6b) remains relatively preserved throughout cul-
ture. Immunohistochemical staining for Connexin 43 demonstrates maintenance of well-organized gap junctions 
at the intercalated disc during 96 hour culture (Fig. 6c). However, it is important to note that without electrical or 
mechanical loading, sarcomeric structure and gap junction alignment is likely to remodel.
Figure 5. Application of the Slice Model System in Acute Versus Chronic Drug Testing. An acute versus 
chronic drug model is developed utilizing donor slices from the human ventricle. (a) A simplified timeline 
of the experimental protocol is shown. Various color corresponds to condition where optical measurement is 
taken. (b) Representative optical action potentials from control untreated ventricular slices (turquoise), slices 
treated acutely with α 1-AR stimulation (15 min, red), control cultured slices (24 Hrs, blue), acutely treated 
slice after control culture (15 min, orange) and chronic α 1-AR treatment (24 Hrs, green). (c,d) Restitution 
curves taken at each condition. Acute α 1-AR stimulation both during baseline and control culture upshifted 
the restitution curve significantly while chronic α 1-AR stimulation downshifted restitution (colored asterisk 
indicate significant difference of corresponding colored AP duration compared to baseline). (e) Statistical 
difference is calculated for AP duration between each condition at 1 Hz pacing frequency. Significant difference 
is observed whenever α 1-AR stimulation is applied both acutely and chronically. Acute α 1-AR stimulation 
increased AP duration, while chronic stimulation decreased AP duration. (f) Conversely, at 1 Hz pacing 
frequency, acute α 1-AR stimulation significantly decreased transverse conduction velocity, albeit more 
prominently in fresh slices. However, chronic α 1-AR stimulation increased transverse conduction velocity.
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Discussion
By adapting and optimizing existing organotypic slice protocols, we successfully procured healthy culture ready 
atrial and ventricular slices from donor and failing human hearts. Acute optical mapping provided functional 
characteristics of slices comparable to traditional intact preparations. Twenty to thirty slices can be prepared 
from a small cubic tissue sample for optical mapping, culture, and viral infection. This approach allows high 
throughput, high resolution, and high accuracy screening of putative therapies for cardiac efficacy and/or toxicity.
Slice validation using optical mapping. Multi-electrode array (Multi-Channel System) have been the 
most popular tool in electrophysiology studies of cardiac slices. Drawbacks of this approach include relatively 
low resolution and ambiguity of field potential interpretation. We show the feasibility of using multi-parametric 
optical mapping in human cardiac slices. Optical mapping provides high spatial and temporal resolution along 
with the ability to measure various parameters: transmembrane potential, intracellular calcium, inner membrane 
potential in mitochondria, etc. Left ventricular AP and Calcium recorded in both donor and failing slices were 
comparable to those recorded in both isolated primary cells and left ventricular wedge. Due to well known trans-
mural electrophysiological differences in the left ventricle, in this study we used slices from the sub-endocardium 
mostly from the same location, 3rd–8th slice from endocardium.
Figure 6. Adenoviral-mediated Gene Expression in Adult Human Ventricular Slices. Ventricular slices are 
transduced with adenovirus encoding eGFP shortly after harvesting. (a) Expression of eGFP in slices at time 
of harvest (0 Hours), and after 48, 72, and 96 Hours in culture. The lower panels show merged green (GFP), 
red (α -actinin) and blue (DAPI, nuclei) channels. Boxed regions are magnified in the top panels to show 
green (left) and red (right) channels separately. After 48 Hours, eGFP expression is robust in cardiomyocytes, 
as well as in non-myocytes, and eGFP expression persists throughout 96 Hours in culture. α -actinin 
staining demonstrates preservation of the sarcomeric structure throughout prolonged culture. (b) Masson’s 
Trichrome staining demonstrates preservation of ventricular slice structure throughout prolonged culture. 
(c) Immunohistochemical staining for Connexin 43, the main gap junction protein isoform expressed in 
human ventricular tissue, demonstrates maintenance of well-organized gap junctions at the intercalated disc 
throughout prolonged culture (white arrowheads).
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Platform for studying human atria. AP mapping of coronary perfused human atrial preparations have 
been previously published by our laboratory31. However, human atrial calcium dynamics remained unknown. 
Our previous human atrial experiments required intact global or regional coronary perfusion, which was 
extremely difficult to achieve, making such experiments challenging to perform32. In contrast, cardiac slices alle-
viate this problem, since they do not require coronary perfusion. Slices can be prepared from any viable atrial 
regions, including biopsies. Approximately 5–10 slices can be made from each piece of atrial tissue.
In some atrial slices, we observed automaticity suggesting that there is a primary or secondary pacemaker 
present in these slices. For example, we observed automaticity in slices sectioned from the SA nodal region. 
Similarly, this approach can be used for systematic mapping of secondary or pathological pacemakers throughout 
the atria. Furthermore, different cell types could also be observed through the morphological differences in APs 
and CaT. The shorter AP/CaT region represents the working myocytes, whereas the longer AP/CaT regions with 
slower upstroke represent the pacemaker cells. Additionally, restitution properties of the two regions are distinctly 
different. While at 1 Hz pacing both regions were captured 1:1, at higher frequency this is no longer the case: at 
600 ms and 400 ms pacing cycle lengths we observed 2:1 and 3:1 capture in SA node, respectively.
Comprehensive model for pre-clinical drug testing. Recent reports shed light on an important, but 
often neglected difference between acute and chronic effects of drugs on electrophysiological targets34,38,39. Using 
human cardiac slices, we show here that acute versus chronic application of phenylephrine results in an opposite 
effect on APD. Clearly, there is an important signaling pathway activated by phenylephrine during chronic appli-
cation, which remains to be explored in future studies. Isolated human primary cells and human coronary per-
fused preparations have a short lifetime, precluding long-term studies involving proliferative signaling. Animal 
models and human iPSC-derived cardiomyocytes could be used for chronic remodeling studies, but they offer 
limited recapitulation of adult human physiology. Thus, organotypic human cardiac slice offers a unique clinically 
relevant model for both acute and chronic human testing ex vivo.
Adenoviral-mediated expression of eGFP. Gene therapy/editing has been advocated for numerous dis-
eases. However, examples of successful clinical translation in the cardiovascular field are relatively few. We used 
eGFP as a proof of concept to suggest that organotypic human heart slice could be used to test the effects of exog-
enous genes expression in pre-clinical validation studies prior to embarking on costly human clinical trials. For 
example, an ideal viral vector would be available at high titers, have limited pre-formed immunity, and evade a 
host immune response to prevent dose-related toxicities. Adeno-associated virus (AAV) is currently being tested 
in clinical trials for myocardial gene delivery. Despite many useful properties of AAV, including prolonged in vivo 
expression and minimal immune response, significant limitations include difficulty producing sufficiently high 
titers, its restricted packaging capacity, and slow kinetics of transgene expression, which limits many applications. 
On this basis, several groups are adapting adenovirus (Ad) for cardiovascular gene therapy applications40–43. In 
this regard, two key facets of the Ad vector currently limiting its fullest utility are its dependence on the coxsacki-
evirus and adenovirus receptor (CAR) for infectivity, and host anti-vector immune response. Strategies to confer 
Ad5 vectors CAR-independent myocardial tropism and evade a host immune response are underway, as previ-
ously described in other organ systems, which may expand the limits of gene packaging capability and enable the 
use of cell-type specific and inducible cardiac promoters for therapeutic applications44.
Pre-clinical platform for novel therapies. Organotypic culture is an effective tool for cell therapies of 
diseases in central nervous system7. Similarly, adult human atrial and ventricular slices provide a versatile and 
potentially high throughput model for pre-clinical trials of novel therapeutic strategies. Acute administration of 
β -adenergic stimulation showed expected response on the APD and CV. Unexpectedly, acute versus chronic α 1 
-adrenergic stimulation had opposite effects on APD and CV. This platform offers a unique adult human-specific 
platform for studying both acute (i.e. flight-or-flight) and chronic (i.e. proliferative) signaling at the tissue level. 
Various putative therapies could be tested in such platform, including pharmacological therapy, virally-medicated 
gene therapy, gene editing, cell therapy, tissue engineering, microRNA, gene editing, and device therapy.
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